Dr. Arlen is the  President, CEO and Chief Medical Officer of Precision Biologics. Prior to joining Precision Biologics, Inc., he served as President, CEO, and Chief Medical Officer at Neogenix Oncology, Inc. Dr. Arlen spent 11 years at the National Cancer Institute, USA, most recently as the...

Dr  Norman Begg is head of Scientific Affairs and Public Health at GlaxoSmithKline Vaccines, in Wavre, Belgium. He has held a number of positions since joining GSK in 2000, including clinical development (paediatric vaccines) and Chief Medical Officer. He is a public health physician who worked for ...

Tanja de Gruijl heads the Immunotherapy and Immune monitoring Lab at the Cancer Center of the VU University medical center (VUmc) in Amsterdam, where she has been appointed Professor of Translational Tumour Immunology. Her research ranges from preclinical topics to immune monitoring of Phase I-III...

Ali Harandi is a chief scientist and lab head at University of Gothenburg with long standing interest in vaccine research, in particular characterization of immune responses to vaccines. Ali Harandi has been serving as principal scientist in several European and international collaborative projects ...

David got his PhD from the Royal Free Hospital, university of London. He joined Immunocore in 2014 and is currently the head of Biomarkers. He expertise is in drug discovery, with focus on oncology and inflammation.

Dr. Krishna Ella is the Chairman & Managing Director of Bharat Biotech International Limited. After early education in Agricultural Sciences, Dr. Ella studied at the University of Hawaii and the University of Wisconsin-Madison. Following a brief stint as a research faculty at the Medical...

Over 20 years of experience working in biotech, coordinating efforts focused on the discovery and development of novel biologic based therapies. Began biotechnology career at Human Genome Sciences, where directed genomic-based target discovery programs and the preclinical development of various...

Dafne Müller received her doctoral degree from the University of Stuttgart in Germany. At the present she holds a group leader position at the department of Biomedical Engineering at the Institute of Cell Biology and Immunology of the University of Stuttgart. Working in the field of recombinant...

Martin Friede is the coordinator of the Initiative for Vaccine research (IVR) at the World Health Organization in Geneva, Switzerland.  In this position Dr Friede provides leadership to WHO’s activities on vaccine research including development of vaccine research policies, strategies and...

Before joining GeoVax in 2015, Dr. Guirakhoo served in senior management and scientific roles within the biotechnology industry with Vaxess Technologies, Hookipa Biotech, Sanofi Pasteur, Acambis, Inc. and OraVax, Inc. In his scientific career, Dr. Guirakhoo has filed over 90 patent applications and ...

Laura is director of Rosa Brunet Consulting Ltd. She has over 15 years of experience in the pharmaceutical industry, having joined the field after being awarded research fellowships at Cornell University (Ithaca, NY, USA) and the University of Cambridge (Cambridge, UK). She obtained her doctorate...

Responsible for external scientific initiatives and for alliance management and leadership of Sanofi Pasteur’s public-private partnerships in Europe. Catalyst and Alliance Manager for the Innovative Medicines Initiative (IMI) Program. Member of the Research Directors Working Group at Vaccines...

Dr. Maltais is an immunologist by training and holds a Ph.D. in Immunobiology from the Karolinska Institute, where she focused on vaccine adjuvants and vaccine delivery. She has previously worked as Vice President, Corporate Development at Cyto Pulse Sciences Inc., a U.S. company focusing on...

Dr Marie-Paule Kieny was appointed Assistant Director-General at the World Health Organization (WHO) in October 2010 and is now leading the Health Systems and Innovation cluster. Prior to this, Dr Kieny directed the WHO Initiative for Vaccine Research since its inception in 2001. Major successes...

Dr. Vidadi M. Yusibov, the Executive Director of Fraunhofer USA Center for Molecular Biotechnology, is responsible for the oversight of all plant-based vaccine and therapeutics development programs. Dr. Yusibov has been involved in different aspects of plant molecular biology, including molecular...